Adage Capital Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$13.4M Buy
1,432,440
+800,800
+127% +$7.5M 0.02% 552
2025
Q1
$7.76M Buy
631,640
+9,800
+2% +$120K 0.01% 634
2024
Q4
$8.22M Sell
621,840
-195,760
-24% -$2.59M 0.01% 652
2024
Q3
$15.7M Sell
817,600
-42,400
-5% -$816K 0.03% 510
2024
Q2
$17.7M Sell
860,000
-40,000
-4% -$821K 0.03% 467
2024
Q1
$21.4M Hold
900,000
0.04% 430
2023
Q4
$19.4M Sell
900,000
-100,000
-10% -$2.16M 0.04% 428
2023
Q3
$14.5M Buy
1,000,000
+75,000
+8% +$1.09M 0.03% 481
2023
Q2
$19.4M Buy
925,000
+135,000
+17% +$2.83M 0.04% 413
2023
Q1
$16.7M Sell
790,000
-150,000
-16% -$3.17M 0.04% 480
2022
Q4
$23.9M Sell
940,000
-310,000
-25% -$7.89M 0.06% 375
2022
Q3
$30M Buy
1,250,000
+12,700
+1% +$305K 0.07% 290
2022
Q2
$23.8M Buy
1,237,300
+158,659
+15% +$3.05M 0.05% 368
2022
Q1
$18.7M Sell
1,078,641
-121,359
-10% -$2.11M 0.04% 477
2021
Q4
$26.3M Sell
1,200,000
-1,666,272
-58% -$36.5M 0.05% 385
2021
Q3
$54.8M Buy
2,866,272
+375,000
+15% +$7.17M 0.11% 198
2021
Q2
$42.8M Buy
2,491,272
+741,272
+42% +$12.7M 0.08% 248
2021
Q1
$39.1M Sell
1,750,000
-80,439
-4% -$1.8M 0.08% 264
2020
Q4
$40.7M Buy
1,830,439
+130,439
+8% +$2.9M 0.09% 243
2020
Q3
$25.1M Buy
1,700,000
+650,000
+62% +$9.59M 0.06% 330
2020
Q2
$15.6M Buy
1,050,000
+50,000
+5% +$741K 0.04% 448
2020
Q1
$11M Sell
1,000,000
-250,000
-20% -$2.74M 0.03% 452
2019
Q4
$11M Hold
1,250,000
0.03% 524
2019
Q3
$9.34M Sell
1,250,000
-225,000
-15% -$1.68M 0.02% 528
2019
Q2
$13.7M Sell
1,475,000
-75,000
-5% -$698K 0.03% 449
2019
Q1
$8.14M Buy
+1,550,000
New +$8.14M 0.02% 553